CD123 (9F5) PE Catalog number 649453 Analyte Specific Reagent
FDA Device Recall #Z-1375-2015 — Class II — March 23, 2015
Recall Summary
| Recall Number | Z-1375-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 23, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | BD Biosciences, Systems & Reagents |
| Location | San Jose, CA |
| Product Type | Devices |
| Quantity | 9 |
Product Description
CD123 (9F5) PE Catalog number 649453 Analyte Specific Reagent
Reason for Recall
One lot of BD CD123 PE (ASR) has been determined to contain a low amount of CD4 antibody and may result in an unexpected staining pattern.
Distribution Pattern
US Distribution in states of: MO, GA, AZ, NE, TX, VA
Lot / Code Information
Lot 5008762, Exp 11/30/16.
Other Recalls from BD Biosciences, Systems & Reagents
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2090-2015 | Class III | BD Flow Cytometers; used on all BD FACSCount, B... | Jun 15, 2015 |
| Z-1370-2015 | Class II | BD FACSCalibur; Catalog Numbers 342973, 342975... | Mar 6, 2015 |
| Z-1000-2015 | Class II | CD8 (Leu-2a) PE (In vitro diagnostic), Catalog ... | Dec 19, 2014 |
| Z-1002-2015 | Class II | Anti-Lambda APC-H7, Catalog Number 656157. ... | Dec 19, 2014 |
| Z-2233-2014 | Class III | BD Multi Check CD4 Low Control Catalog No. 340... | Jul 18, 2014 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.